Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2024

Correspondence / Letter

Comment on "Consolidation Osimertinib Versus Durvalumab following Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC".

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Citation & Authors

J Thorac Oncol. 2024;19(5):e6-e7.

Ching-Yi Chen; Guo-Sheng Wang; James Cheng-Chung Wei

Abstract & Original paper

No abstract is available in the public index. Please consult the original paper.

Go to journal page